Table 2.
Demography of patients before and after operation.
| Patient number | Gender | Age | Date of OP. | Date of radioactive I-131 | I-131 Ablation Dose | FT4 Post-OP. | hsTSH Post-OP. | Tg Pre-OP. | Tg Post-OP. 6 months | Anti-Tg Ab Post-OP. 6 months | Pathology |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 49 | 20160820 | 20160929 | 30 mCi | 0.981 | 0.212 | 93.6 | <0.2 | <3.0 | PTC with minimally extra-thyroid soft tissue involvement, |
| TNM: T3N0M0 | |||||||||||
| 2 | F | 58 | 20160908 | NA | NA | 1.13 | 2.12 | NA | <0.2 | 50.4 | PTC with clear surgical margin, |
| TNM: T1aN0M0 | |||||||||||
| 3 | F | 57 | 20160912 | 20161014 | 30 mCi | 1.24 | 2.96 | NA | <0.2 | <3.0 | PTC with minimally extra-thyroid soft tissue involvement, central lymph |
| nodes dissection | |||||||||||
| TNM: T3N0M0 | |||||||||||
| 4 | F | 42 | 20160912 | 20161014 | 30 mCi | 1.24 | 0.611 | <0.2 | <0.2 | 6.03 | PTC |
| TNM: T1bN1aM0 | |||||||||||
| 5 | F | 34 | 20161015 | 20161118 | 30 mCi | 1.07 | 11.3 | NA | <0.2 | <3.0 | PTC with minimally capsular invasion, |
| TNM: T3N0M0 | |||||||||||
| 6 | F | 52 | 20161119 | NA | NA | 1.01 | 0.249 | NA | 3.8 | 4.47 | PTC |
| TNM: T2N0M0 | |||||||||||
| 7 | F | 43 | 20161208 | 20170120 | 30 mCi | <0.27 | 233 | NA | <0.2 | NA | PTC |
| TNM: T1bN0M0 | |||||||||||
| 8 | M | 48 | 20161205 | 20170112 | 30 mCi | 0.372 | 57.7 | NA | <0.2 | NA | Right thyroid follicular carcinoma |
| TNM: T1bN0M0 | |||||||||||
| 9 | M | 41 | 20170422 | 20170720 | 150 mCi | 2.23 | 0.059 | NA | 27.4 | 3.46 | Papillary carcinoma, with minimal extrathyroid extension, |
| TNM: T3N0M1 (lung) | |||||||||||
| 10 | F | 59 | 20170410 | NA | NA | 1.27 | 0.96 | NA | 9.14 | <3.0 | Papillary microcarcinoma |
| TNM: T1aN0M0 | |||||||||||
| 11 | F | 45 | 20170318 | 20170421 | 30 mCi | 0.963 | 118 | NA | <0.2 | <3.0 | PTC (multifoci) |
| TNM: T3N0M0 | |||||||||||
| 12 | F | 41 | 20170501 | 20170726 | 125 mCi | 1.32 | 0.998 | 1.34 | <0.2 | 119.52 | PTC |
| TNM: T1bN1aM0 | |||||||||||
| 13 | M | 49 | 20161015 | NA | NA | 0.999 | 1.51 | 29.4 | 15.9 | <3.0 | PTC |
| TNM: T3N0M0 | |||||||||||
| 14 | F | 39 | 20170619 | 20170721 | 30 mCi | 1.25 | 1.9799 | 46.2 | <0.2 | <3.0 | PTC |
| TNM: T1aN1aM0 | |||||||||||
| 15 | F | 74 | 20170828 | 20170929 | 30 mCi | 1.12 | 0.202 | 14.1 | <0.2 | <3.0 | PTC |
| TNM: T1aN1aM0 | |||||||||||
| 16 | F | 31 | 20171005 | 20180208 | 100 mCi | 1.29 | 1.9095 | 57.6 | 0.217 | <3.0 | PTC |
| TNM: T3N1bM0 |
T1 or T2: patients 2, 6, 7, 8, 10; T3 or lymph nodes metastasis: patients 1, 4, 5, 11, 12, 13, 14, 15, 16;
T3 with distant metastasis or suspect delphian lymph nodes metastasis: patients 3, 9.